TAKEDA PHARMACEUTICAL CO LTD
SEC insider (Form 3/4/5 filer). CIK 0001395064. 10% Owner at Ovid Therapeutics Inc. (OVID) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Dec 8, 2025. Located in CHUO-KU, TOKYO, M0.
Companies TAKEDA PHARMACEUTICAL CO LTD has filed insider reports for
- Ovid Therapeutics Inc. (OVID): 10% Owner
- HilleVax, Inc. (HLVX): 10% Owner
TAKEDA PHARMACEUTICAL CO LTD
CIK: 0001395064
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
